T1	Participants 131 154	different subgroups wit
T2	Participants 156 191	glucocorticoid-induced osteoporosis
T3	Participants 580 607	patients on glucocorticoids
T4	Participants 744 771	different patient subgroups
T5	Participants 1384 1403	patients â‰¤ 74 years
T6	Participants 1434 1443	65-74 yea
T7	Participants 1874 1990	Osteoporotic patients in the prevention (P=0.0189) and osteopenic patients in the treatment subpopulation (P=0.0305)
